RANKINGS

POPULAR STOCKS

Guardant Health, Inc.

NasdaqGS:GH

Location

United States

Market Cap

USD 6.20 B

Share Price

USD 50.03

Avg Daily Volume

2,292,665

Change (1 day)

0.26%

Change (1 year)

70.23%

Change (YTD)

63.76%

Guardant Health, Inc. Inventory for the year ending December 31, 2024: USD 71.08 M

Guardant Health, Inc. Inventory is USD 71.08 M for the year ending December 31, 2024, a 14.75% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.
  • Guardant Health, Inc. Inventory for the year ending December 31, 2023 was USD 61.95 M, a 20.06% change year over year.
  • Guardant Health, Inc. Inventory for the year ending December 31, 2022 was USD 51.60 M, a 68.21% change year over year.
  • Guardant Health, Inc. Inventory for the year ending December 31, 2021 was USD 30.67 M, a 35.03% change year over year.
  • Guardant Health, Inc. Inventory for the year ending December 31, 2020 was USD 22.72 M, a 49.63% change year over year.
Key data
Date Inventory Current Assets Property, Plant, Equipment (Net) Total Assets
Market news
NasdaqGS: GH

Guardant Health, Inc.

CEO Dr. Helmy Eltoukhy Ph.D.
IPO Date Oct. 4, 2018
Location United States
Headquarters 505 Penobscot Drive
Employees 1,999
Sector 🏥 Health Care
Industries
Clinical Trials
🧬 Biotechnology
💻 Telehealth
Description

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

Similar companies

BSX

Boston Scientific Corporation

USD 104.58

0.28%

SHL.DE

Siemens Healthineers AG

USD 54.80

0.08%

GEHC

GE HealthCare Technologies Inc.

USD 74.86

2.90%

NTRA

Natera, Inc.

USD 168.17

2.44%

LH

Laboratory Corporation of America Holdings

USD 256.98

-0.66%

BAX

Baxter International Inc.

USD 30.50

-0.36%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 37.60

0.25%

ICLR

ICON Public Limited Company

USD 146.75

0.58%

RGC

Regencell Bioscience Holdings Limited

USD 20.19

-7.09%

ASND

Ascendis Pharma A/S

USD 172.95

-0.03%

EXAS

Exact Sciences Corporation

USD 51.81

-0.21%

CTEC.L

ConvaTec Group Plc

USD 3.97

0.12%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 7.86

-1.68%

DIA.MI

DiaSorin S.p.A.

USD 109.98

0.72%

688617.SS

APT Medical Inc.

USD 41.08

1.04%

LNTH

Lantheus Holdings, Inc.

USD 80.74

0.24%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-0.25%

TMDX

TransMedics Group, Inc.

USD 130.06

1.15%

ADMA

ADMA Biologics, Inc.

USD 18.40

4.54%

LAURUSLABS.NS

Laurus Labs Limited

USD 7.94

1.94%

IPCALAB.NS

Ipca Laboratories Limited

USD 15.69

-0.60%

INSP

Inspire Medical Systems, Inc.

USD 129.71

-1.74%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 4.04

2.16%

002603.SZ

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

USD 1.96

0.12%

PFIZER.NS

Pfizer Limited

USD 66.25

2.27%

300676.SZ

BGI Genomics Co., Ltd.

USD 6.91

0.75%

ERIS.NS

Eris Lifesciences Limited

USD 18.88

-0.23%

LIVN

LivaNova PLC

USD 45.80

-0.15%

300529.SZ

Jafron Biomedical Co.,Ltd.

USD 2.99

0.21%

VIMIAN.ST

Vimian Group AB (publ)

USD 4.12

-2.57%

VCYT

Veracyte, Inc.

USD 26.81

1.36%

BAVA.CO

Bavarian Nordic A/S

USD 26.70

1.60%

0853.HK

MicroPort Scientific Corporation

USD 1.11

1.19%

VITR.ST

Vitrolife AB (publ)

USD 14.53

2.24%

NVCR

NovoCure Limited

USD 17.10

-1.33%

QDEL

QuidelOrtho Corporation

USD 28.70

2.10%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 4.09

3.84%

HRMY

Harmony Biosciences Holdings, Inc.

USD 31.86

0.92%

ADPT

Adaptive Biotechnologies Corporation

USD 12.16

1.50%

CERT

Certara, Inc.

USD 11.42

5.16%

ARQT

Arcutis Biotherapeutics, Inc.

USD 14.40

-0.48%

002287.SZ

Tibet Cheezheng Tibetan Medicine Co., Ltd.

USD 3.13

0.29%

688289.SS

Sansure Biotech Inc.

USD 2.85

0.72%

INDGN.NS

Indegene Limited

USD 6.71

-0.64%

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

USD 1.66

-0.44%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.52

0.52%

002020.SZ

Zhejiang Jingxin Pharmaceutical Co., Ltd.

USD 1.80

-0.18%

605507.SS

Guobang Pharma Ltd.

USD 2.75

0.44%

688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

USD 12.27

0.36%

ABBV

AbbVie Inc.

USD 186.79

0.76%

StockViz Staff

June 28, 2025

Any question? Send us an email